Articles

Leprosy drug clofazimine activates peroxisome proliferator-activated receptor-γ and synergizes with imatinib to inhibit chronic myeloid leukemia cells

Division of Biochemistry, CSIR-Central Drug Research Institute, Lucknow
Division of Biochemistry, CSIR-Central Drug Research Institute, Lucknow;AcSIR, CSIR-Central Drug Research Institute Campus, Lucknow
Division of Biochemistry, CSIR-Central Drug Research Institute, Lucknow
Division of Molecular and Structural Biology, CSIR-Central Drug Research Institute, Lucknow
Zydus Research Center, Moraiya, Ahmedabad, Gujarat
Zydus Research Center, Moraiya, Ahmedabad, Gujarat
Division of Biochemistry, CSIR-Central Drug Research Institute, Lucknow;AcSIR, CSIR-Central Drug Research Institute Campus, Lucknow
Division of Biochemistry, CSIR-Central Drug Research Institute, Lucknow
Division of Biochemistry, CSIR-Central Drug Research Institute, Lucknow
Division of Molecular and Structural Biology, CSIR-Central Drug Research Institute, Lucknow
Division of Molecular and Structural Biology, CSIR-Central Drug Research Institute, Lucknow
Developmental Toxicology Laboratory, Systems Toxicology and Health Risk Assessment Group, CSIR-Indian Institute of Toxicology Research, Lucknow
Pharmacokinetics and Metabolism Division, CSIR-Central Drug Research Institute, Lucknow
Zydus Research Center, Moraiya, Ahmedabad, Gujarat
Zydus Research Center, Moraiya, Ahmedabad, Gujarat
Sophisticated Analytical Instrument Facility, CSIR-Central Drug Research Institute, Lucknow
Pharmacokinetics and Metabolism Division, CSIR-Central Drug Research Institute, Lucknow;AcSIR, CSIR-Central Drug Research Institute Campus, Lucknow
Developmental Toxicology Laboratory, Systems Toxicology and Health Risk Assessment Group, CSIR-Indian Institute of Toxicology Research, Lucknow
Zydus Research Center, Moraiya, Ahmedabad, Gujarat
Zydus Research Center, Moraiya, Ahmedabad, Gujarat
Department of Clinical Hematology and Medical Oncology, King George’s Medical University, Lucknow, Uttar Pradesh
Division of Biochemistry, CSIR-Central Drug Research Institute, Lucknow;AcSIR, CSIR-Central Drug Research Institute Campus, Lucknow
Division of Endocrinology, CSIR-Central Drug Research Institute, Lucknow, India;AcSIR, CSIR-Central Drug Research Institute Campus, Lucknow
AcSIR, CSIR-Central Drug Research Institute Campus, Lucknow;Division of Molecular and Structural Biology, CSIR-Central Drug Research Institute, Lucknow
Division of Biochemistry, CSIR-Central Drug Research Institute, Lucknow;AcSIR, CSIR-Central Drug Research Institute Campus, Lucknow
Vol. 105 No. 4 (2020): April, 2020 https://doi.org/10.3324/haematol.2018.194910